Eventi
A French SME has developed a personalized medicine software platform focused to improve the management of inflammatory diseases in rheumatology. From a simple blood sample, the platform predicts the effectiveness of a treatment before its prescription based on the analysis of specifics biomarkers of the patient. The French SME is looking for a research partner specialized in blood samples and autoimmune diseases in order to test the performance of the platform within an Eurostars project
Partner Sought
Type: Biotech/Pharma/Medtech companies with access to a biobank specializing in rheumatoid arthritis and other autoimmune diseases.
Role: to allow the assessment of the biomarkers necessary for the device in RA patient samples to validate the performance of the algorithms for biologics response prediction in rheumatology.
The partner will play a crucial role in the selection and validation of the biomarkers, and in the evaluation of the appropriate biotherapy of rheumatoid patients.
A licence agreement can be discussed as a result of the project.
Type and Size of Partner Sought: 251-500, R&D Institution, SME 11-50, SME 51-250, University
Type of Partnership Considered: Research cooperation agreement
Call
Framework Programme: Eureka
Call title and identifier: Eurostars 2018 - September call
Coordinator Required: no
Deadline for EOI: 17 Aug 2018
Deadline for Call: 13 Sep 2018
Keywords
Technology Keywords: 06001002 Clinical Research, Trials, 06001005 Diagnostics, Diagnosis, 06001012 Medical Research, 06005003 Health information management
Market Keywords: 02007002 Database and file management, 02007007 Applications software, 02007017 Expert systems, 05001003 Differential diagnosis
Info e Contatti
Per maggiori informazioni sul profilo e per inviare una manifestazione di interesse clicca qui
Oppure contattare:
Roberta Alberti, email: een1@confindustria.lombardia.it, tel: 02 58370812-800
